Facilities Featured Articles

  1. API Manufacturing: Strategic Partnering Preferences With CMOs Vary Among Small-Molecule, High-Potency And Biologic API 10/3/2013

    Data compiled from a strategic partner survey for outsourcing commercial-scale drug substance projects in API manufacturing revealed the differences in how buyers think about strategic partnerships with contract manufacturers.

  2. Teva Explores The Common Ground Of Follow-On And Innovative Pharma 10/2/2013

    Teva’s new CEO Jeremy Levin explains the company’s future in “high-value generics” and innovative treatments in CNS, respiratory, and other areas.

  3. The Key To Continuous Manufacturing 9/3/2013

    Ivo Backx points out that integration of all process automation architectures is essential if continuous manufacturing is to be rolled out successfully.

  4. Pfizer's Hybrid Approach To Implementing Continuous Manufacturing Processes 8/30/2013

    Kevin Nepveux, VP of global technology services with in Pfizer Global Supply shares his insights about continuous manufacturing and how Pfizer is deploying continuous and batch processes as a hybrid approach toward improving manufacturing efficiencies. Kevin Nepveux says “I think one of the best ways to go about implementing CM processes is to develop the analytics in line with the application.”

  5. Maximize Return; Minimize Risk (Important Things To Consider When Closing A Lab) 6/3/2013

    Whether a small enterprise or large institution, many organizations have and will be faced with the challenge of closing a lab. No matter what the size or scope of the closure, the person tasked with closing the facility faces a daunting assignment: millions of dollars in real estate, laboratory equipment, and research devices will need to be redeployed, sold, or disposed of.  By Tom Burton, President Liquidity Services’ Capital Asset Group

  6. The Shifting Geography Of Life Sciences Innovation 5/30/2013

    The life science industry is experiencing change at a pace that is forcing companies to examine how they should operate and innovate more effectively.

  7. Sustainability In Life Sciences To Drive Revenue And Reduce Costs 5/30/2013

    Adopting sustainable business practices that decrease the amount of water, energy and other resources used in R&D, manufacturing, and the transport of medical products has become a nuts-and-bolts financial issue.

  8. Seamlessly Upgrade Your Mixing Operation 7/11/2011

    Improving manufacturing process efficiencies is a continuous endeavor in the life sciences industry. In today’s fiercely competitive markets, it has become necessary to regularly evaluate cost position to increase profitability and customer satisfaction. By Christine Banaszek, Charles Ross & Son Company

  9. The Right Biomanufacturing Partner Can Mitigate Forecasting Risks

    While forecasts can never be 100-percent accurate, the goal for biopharmaceutical forecasters should be to minimize the degree of inaccuracies as much as possible.

  10. Solving The OOS Problem With Continuous Manufacturing

    With continuous manufacturing, it is possible to monitor product quality continuously, and make adjustments in real time to keep the product in spec.